首页> 外文期刊>BMC Medical Genetics >Functional effects of the TMEM43 Ser358Leu mutation in the pathogenesis of arrhythmogenic right ventricular cardiomyopathy
【24h】

Functional effects of the TMEM43 Ser358Leu mutation in the pathogenesis of arrhythmogenic right ventricular cardiomyopathy

机译:TMEM43 Ser358Leu突变在致心律失常性右室心肌病发病机制中的功能作用

获取原文
           

摘要

Background The Ser358Leu mutation in TMEM43 , encoding an inner nuclear membrane protein, has been implicated in arrhythmogenic right ventricular cardiomyopathy (ARVC). The pathogenetic mechanisms of this mutation are poorly understood. Methods To determine the frequency of TMEM43 mutations as a cause of ARVC, we screened 11 ARVC families for mutations in TMEM43 and five desmosomal genes previously implicated in the disease. Functional studies were performed in COS-7 cells transfected with wildtype, mutant, and 1:2 wildtype:mutant TMEM43 to determine the effect of the Ser358Leu mutation on the stability and cellular localization of TMEM43 and other nuclear envelope and desmosomal proteins, assessed by solubility assays and immunofluorescence imaging. mRNA expression was assessed of genes potentially affected by dysfunction of the nuclear lamina. Results Three novel mutations in previously documented desmosomal genes, but no mutations in TMEM43 , were identified. COS-7 cells transfected with mutant TMEM43 exhibited no change in desmosomal stability. Stability and nuclear membrane localization of mutant TMEM43 and of lamin B and emerin were normal. Mutant TMEM43 did not alter the expression of genes located on chromosome 13, previously implicated in nuclear envelope protein mutations leading to skeletal muscular dystrophies. Conclusions Mutant TMEM43 exhibits normal cellular localization and does not disrupt integrity and localization of other nuclear envelope and desmosomal proteins. The pathogenetic role of TMEM43 mutations in ARVC remains uncertain.
机译:背景技术TMEM43的Ser358Leu突变编码一种核内膜蛋白,与心律失常性右室心肌病(ARVC)有关。对该突变的致病机理了解甚少。方法为了确定引起ARVC的TMEM43突变的频率,我们筛选了11个ARVC家族中TMEM43的突变以及以前与该疾病有关的5个桥粒基因。在转染了野生型,突变型和1:2野生型:突变型TMEM43的COS-7细胞中进行了功能研究,以确定Ser358Leu突变对TMEM43以及其他核包膜和桥粒蛋白的稳定性和细胞定位的影响(通过溶解度评估)分析和免疫荧光成像。评估了可能受核层功能障碍影响的基因的mRNA表达。结果在先前记录的桥粒基因中发现了三个新突变,但在TMEM43中未发现突变。用突变体TMEM43转染的COS-7细胞在桥粒稳定性上没有变化。突变体TMEM43以及层粘连蛋白B和emerin的稳定性和核膜定位正常。 TMEM43突变体不会改变13号染色体上基因的表达,该基因先前与导致骨骼肌营养不良的核膜蛋白突变有关。结论突变体TMEM43表现出正常的细胞定位,并且不会破坏其他核被膜和桥粒蛋白的完整性和定位。 TMEM43突变在ARVC中的致病作用仍然不确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号